Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy: A Multicenter, Prospective, Observational, Pan-Cancer Cohort Study with a Gender Perspective

Baseline Circulating Blood Cell Counts and Ratios and Changes Therein for Predicting Immune-Related Adverse Events during Immune Checkpoint Inhibitor Therapy: A Multicenter, Prospective, Observational, Pan-Cancer Cohort Study with a Gender Perspective

Several factors have been associated with the occurrence of immune-related adverse events (irAEs) induced by immune checkpoint inhibitor (ICI) therapy. Despite their availability, the predictive value of circulating blood cell parameters remains underexplored. Our aim was to investigate whether base...

Full description

Bibliographic Details
Main Authors: Lucía Teijeira, Mireia Martínez, Amaia Moreno, Ibone de Elejoste, Berta Ibáñez-Beroiz, Virginia Arrazubi, Isabela Díaz de Corcuera, Iñaki Elejalde, Ana Campillo-Calatayud, Iñigo Les
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Cancers
Subjects:
immune checkpoint inhibitors
immune-related adverse events
gender perspective
cancer
prediction
blood cell counts
Online Access:https://www.mdpi.com/2072-6694/16/1/151

Internet

https://www.mdpi.com/2072-6694/16/1/151

Similar Items